Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lutz

Showing results (291-300 of 346) with videos related to

Pageof 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische OnkologieManfred P Lutz, Hansjochen Wilke, D J Theo Wagener, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM studyF Namouni, F Doz, M L Tanguy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2012
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)T Ruers, C Punt, F Van Coevorden, et al.
Medical and Pediatric Oncology|February 25, 1998
Molecular monitoring of tumor cell contamination in leukapheresis products from stage IV neuroblastoma patients before and after positive CD34 selectionA Tchirkov, J Kanold, M Giollant, et al.
British Journal of Cancer|June 12, 2003
Genetic alterations in primary osteosarcoma from 54 children and adolescents by targeted allelotypingN Entz-Werle, A Schneider, C Kalifa, et al.
ESMO Open|February 18, 2022
ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspectiveT Koessler, M Alsina, D Arnold, et al.
Nature Materials|March 9, 2017
Direct 3D mapping of the Fermi surface and Fermi velocityK Medjanik, O Fedchenko, S Chernov, et al.
Bone Marrow Transplantation|December 10, 2013
Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI+CY versus BU+CY: a report from the Société Française de Greffe de Moelle et de Thérapie CellulaireE de Berranger, A Cousien, A Petit, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2016
Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectivesMarkus Moehler, Maike Delic, Katrin Goepfert, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2025
Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysisGiacomo Bregni, Bryan Leurquin, Peggy Giasafaki, et al.
Pageof 35

Showing results (291-300 of 346) with videos related to

Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische OnkologieManfred P Lutz, Hansjochen Wilke, D J Theo Wagener, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM studyF Namouni, F Doz, M L Tanguy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2012
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)T Ruers, C Punt, F Van Coevorden, et al.
Medical and Pediatric Oncology|February 25, 1998
Molecular monitoring of tumor cell contamination in leukapheresis products from stage IV neuroblastoma patients before and after positive CD34 selectionA Tchirkov, J Kanold, M Giollant, et al.
British Journal of Cancer|June 12, 2003
Genetic alterations in primary osteosarcoma from 54 children and adolescents by targeted allelotypingN Entz-Werle, A Schneider, C Kalifa, et al.
ESMO Open|February 18, 2022
ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspectiveT Koessler, M Alsina, D Arnold, et al.
Nature Materials|March 9, 2017
Direct 3D mapping of the Fermi surface and Fermi velocityK Medjanik, O Fedchenko, S Chernov, et al.
Bone Marrow Transplantation|December 10, 2013
Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI+CY versus BU+CY: a report from the Société Française de Greffe de Moelle et de Thérapie CellulaireE de Berranger, A Cousien, A Petit, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2016
Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectivesMarkus Moehler, Maike Delic, Katrin Goepfert, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2025
Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysisGiacomo Bregni, Bryan Leurquin, Peggy Giasafaki, et al.
Pageof 35